Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Advanced Magnetics in-licenses contrast agent from Andaris

March 10, 1998

Matritech: Q4 and year-end 1997 highlights

March 6, 1998

Cytogen: Q4 and year-end 1997 highlights

March 4, 1998

FDA requests additional information for EchoGen NDA review

March 2, 1998

UroGenesys licenses prostate cancer gene for diagnostic and therapeutic development

Feb. 27, 1998

Thyrogen will receive priority review by the FDA; EU application also accepted

Feb. 26, 1998

Diatide issued approvable letter for AcuTect by FDA

Feb. 24, 1998

Company Profile: Mallinckrodt

Feb. 20, 1998

Guilford: FY 1997 highlights

Feb. 18, 1998

Immunomedics terminates CEA-Scan marketing agreements with Mallinckrodt

Feb. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...